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Edited by Vladimir SkulachevAbstract Anemia is a symptom in patients with Pearson syn-
drome caused by the accumulation of mutated mitochondrial
DNA (mtDNA). Such mutated mtDNAs have been detected in
patients with anemia. This suggested that respiration defects
due to mutated mtDNA are responsible for the anemia. How-
ever, there has been no convincing experimental evidence to con-
ﬁrm the pathophysiological relation between respiration defects
in hematopoietic cells and expression of anemia. We address this
issue by transplanting bone marrow cells carrying pathogenic
mtDNA with a large-scale deletion (DmtDNA) into normal mice.
The bone marrow-transplanted mice carried high proportion of
DmtDNA only in hematopoietic cells, and resultant the mice suf-
fered from macrocytic anemia. They show abnormalities of ery-
throid diﬀerentiation and weak erythropoietic response to a
stressful condition. These observations suggest that hematopoi-
etic cell-speciﬁc respiration defects caused by mtDNAs with
pathogenic mutations are responsible for anemia by inducing
abnormalities in erythropoiesis.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Erythropoiesis1. Introduction
Mitochondria of mammalian cells have 103–104 copies of
mitochondrial DNA (mtDNA) per cell, and the mtDNA con-
tains 13 structural genes that encode part of the subunits of
respiratory chain complexes, 22 mitochondrial tRNA genes,
and 2 rRNA genes [1–3]. High accumulation of mtDNA with
pathogenic mutations induces mitochondrial respiration de-
fects, which are associated with mitochondrial diseases [1–3].Abbreviations: mtDNA, mitochondrial DNA; DmtDNA, mitochon-
drial DNA with pathogenic 4696-bp deletion; mito-mice, model mice
for mitochondrial diseases; B6 mice, C57BL/6J mice; WT, wild-type;
BM, bone marrow; RBC, red blood cell; PHZ, phenylhydrazine
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doi:10.1016/j.febslet.2007.03.092It has been suggested that mutations of mtDNAs are closely
associated with aging and age-related disorders, including dia-
betes and neurodegenerative diseases. Furthermore, studies of
patients with Pearson syndrome, which is characterized by
macrocytic anemia with pancytopenia, ringed sideroblasts,
and exocrine pancreatic dysfunction [4], showed large-scale
deletions of mtDNA in hematopoietic cells [5–8]. Mutations
in the cytochrome c oxidase subunit I gene and in the mitochon-
drial tRNALeu(CUN) gene of mtDNA have been also identiﬁed
in hematopoietic cells from patients with acquired idiopathic
sideroblastic anemia [9] and with refractory anemia with excess
blasts [10], respectively. Thus, it is possible that respiration de-
fects caused by the accumulation of mtDNA mutations are
responsible for the anemia. However, there is no convincing
evidence to prove that the mutated mtDNAs induce respira-
tion defects in hematopoietic cells, and that resultant respira-
tion defects are responsible for expression of anemia.
Recently, we generated model mice for mitochondrial dis-
eases (mito-mice) by introducing mitochondria carrying
mtDNA with a pathogenic 4696-bp deletion (DmtDNA) into
zygotes of C57BL/6J (B6) mice [11]. These mito-mice carry
both the DmtDNA and wild-type (WT) mtDNA in all their tis-
sues, whereas they have the same nuclear genetic background
as that of WT B6 mice. The deleted region of the mtDNA in-
cludes six mitochondrial tRNA genes and seven structural
genes. Proportions of DmtDNA increase progressively with
aging owing to their replication advantages, and high accumu-
lation of DmtDNA (>75%) impairs respiration defects due to
decreasing amounts of the six mitochondrial tRNAs but not
of proteins encoded by the seven structural genes [11–13].
Mito-mice with DmtDNA in all their tissues showed systemic
respiratory defects and phenotypes of resultant mitochondrial
diseases, such as anemia, low body weight, lactic acidosis,
myopathy, renal failure, heart blockage [11], deafness [14],
and male infertility [15]. However, this severe systemic pathol-
ogy could give rise to secondary anemia due to chronic disor-
ders. In fact, chronic renal failure is shown to induce renal
anemia. Therefore, it is diﬃcult to clarify, using mito-mice,
whether expression of anemia is due to respiration defects
caused by accumulated DmtDNA in hematopoietic cells or in
renal tissues.
For resolving this problem, we generated a novel in vivo
model by transplanting bone marrow (BM) cells from mito-
mice into WT B6 mice. The results provide direct evidence that
accumulation of DmtDNA and resultant respiration defects inblished by Elsevier B.V. All rights reserved.
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impairment of erythropoiesis.2. Materials and methods
2.1. Mice and BM transplantation
Mito-mice were generated by introduction of DmtDNA from culti-
vated cells into fertilized eggs of B6 mice by using cell fusion tech-
niques as described previously [11]. Before BM transplantation,
recipient mice (12-week-old female WT B6-Ly5.1 mice; RIKEN Bio-
resource Center, Tsukuba, Ibaraki, Japan) were irradiated (9 Gy).
BM cells were isolated from the femur and tibia of 12-week-old male
WT B6-Ly5.2 mice and mito-mice (Ly5.2) by ﬂushing with phos-
phate-buﬀered saline (PBS), and 1 · 106 BM cells in 0.2 mL PBS were
injected into tail veins of the irradiated WT B6 mice.2.2. Estimation of mtDNA proportions
To estimate DmtDNA proportions in hematopoietic cells, we used
real-time monitoring PCR as described previously [13].
2.3. Analyses of mitochondrial respiratory function
Biochemical analyses of respiratory chain complex activities were
carried out as described previously [16].
2.4. Measurement of ATP contents
BM cells (2 · 104) were suspended in 100 lL PBS and placed into 96-
well plates. After addition of 100 lL luciferin–luciferase reagent
(CellTiter-Glo; Promega, Madison, WI, USA), the contents were
mixed for 2 min to induce lysis of BM cells, and incubated at room
temperature for 10 min to stabilize luminescent signals. The lumines-
cent signals were detected by a luminometer (Centro LB960; Berthold
Technologies, Bad Wildbad, Germany).
2.5. Analysis of complete blood count
Peripheral blood was drawn from a retro-orbital vessel into a 1.5-
mL tube containing 50 lL 0.1% EDTA. Hematocrit, red blood cell
(RBC) count, and mean corpuscular hemoglobin concentration were
measured by an automated blood counter (MEK6308; Nihon Kohden,
Shinjuku, Tokyo, Japan).
2.6. Histopathological analyses
Spleens from transplanted mice were ﬁxed in 10% formaldehyde
solution. Paraﬃn sections (5 lm) were stained with hematoxylin and
eosin.
2.7. Flow cytometry
For measurement of RBC lifespan, we performed with a biotin label
method described in Ref. [17,18]. Brieﬂy, N-hydroxysuccinimide
(NHS)–biotin (NHS–biotin E-Z link; 4 mg/mL PBS; Pierce, Rockford,
IL, USA) was injected intravenously into BM-transplanted mice.
Peripheral blood samples (<10 lL) were drawn from the tail vein every
3 days for the ﬁrst 2 weeks after injection, then every 5–6 days in the
third and fourth weeks. Labeled cells were stained with PE-conjugated
streptavidin for 30 min at 4 C in PBS and 5% fetal bovine serum
(staining buﬀer), and then analyzed. For analysis of reticulocytes,
peripheral blood was stained with thiazole orange (Retic-COUNT Re-
agent; BD Biosciences, San Jose, CA, USA) for 30 min at room tem-
perature in dark and measured according to the manufacturer’s
protocol. Spleens were mechanically dissociated by pushing with a syr-
inge plunger through a 70-lm strainer in the presence of staining buf-
fer. Freshly isolated spleen cells were incubated for 30 min with
phycoerythrin (PE)-conjugated anti-Mac1 and Gr1 antibodies, or
anti-CD4 and CD8 antibodies, and allophycocyanin (APC)-conju-
gated anti-B220 or anti-Ter119 antibodies, and ﬁnally with ﬂuorescein
isothiocyanate (FITC)-conjugated anti-Ly5.2 antibody (Bay Biosci-
ence, Kobe, Hyohgo, Japan), respectively, at 4 C in staining buﬀer,
and analyzed. For erythroblast quantitative assay, spleen and BM cells
were incubated for 30 min at 4 C with PE-conjugated anti-CD71 (BD
Biosciences) and APC-conjugated anti-Ter119 (Bay Bioscience) anti-
bodies. For apoptotic analysis, spleen and BM cells were suspended
in annexin-V binding buﬀer, and incubated for 15 min at room temper-ature with FITC-conjugated annexin-V (BD Biosciences) and PE-con-
jugated anti-CD71 (BD Biosciences) and APC-conjugated anti-Ter119
(Bay Bioscience) antibodies, and then diluted in annexin-V binding
buﬀer, and analyzed. Flow cytometry was carried out on FACSCalibur
and FACSVantage SE ﬂow cytometers (Becton Dickinson, Flanklin
Lakes, NJ, USA).
2.8. Statistical analysis
Data were analyzed with an unpaired Student’s t-test. All values are
means ± S.D., and values with P < 0.05 were considered signiﬁcant.3. Results
3.1. Activities of respiratory chain complexes and ATP levels
in BM cells of mito-mice
To conﬁrm that accumulation of DmtDNA in hematopoietic
cells induces mitochondrial respiration defects, we quantiﬁed
activities of respiratory chain complexes in BM cells of mito-
mice and WT B6 mice. We used 5- to 7-month-old mito-mice
carrying 78–82% DmtDNA (n = 5) in their BM cells and age-
matched WT B6 mice (n = 5). Activities of complex I + III
and complex IV, which is cytochrome c oxidase (COX), were
signiﬁcantly reduced, by 61% and 39%, in BM cells of mito-
mice. On the other hand, complex II activity in BM cells of
mito-mice was increased (Fig. 1A). Complex II is composed
of proteins encoded by nuclear genes. This increased activity of
nuclear gene-encoded proteins has been shown in tissues of
mtDNA-related disease patients, however, the mechanism is
still unknown [3]. Thus, high accumulation of DmtDNA signif-
icantly reduces activities of complexes I + III and IV in BM
cells.
To investigate whether these reduced activities reduce the
cellular ATP contents of BM cells, we measured ATP contents
in BM cells of both lines. We used 5- to 7-month-old mito-mice
carrying 77–83% DmtDNA (n = 5) in their BM cells and age-
matched WT B6 mice (n = 5). ATP contents were reduced by
26% in BM cells of mito-mice (Fig. 1B). This result suggests
that high accumulation of DmtDNA in hematopoietic cells de-
creases the activities of respiratory chain complexes, thus
reducing ATP levels.
3.2. Anemic phenotypes resulting from respiration defects in
hematopoietic cells
To generate an in vivo model carrying DmtDNA only in
hematopoietic cells, we transplanted BM cells from mito-mice
into lethally irradiated WT mice, and generated B6/BMDmtDNA
mice. As donor mice, we used three mito-mice, in which BM
cells carried 81–82% DmtDNA. We also generated control
mice (B6/BMWT mice). At 3 months after BM transplantation,
we conﬁrmed that peripheral blood cells of BM-transplanted
mice were reconstituted with donor-derived cells (>85% of T
lymphocytes, >99% of B lymphocytes, and >99% of myeloid
cells). All mice of both groups survived despite at 6 months
after BM transplantation. This result suggests that hematopoi-
etic stem cells of donor mito-mice have long-term repopulation
ability.
If respiration defects in hematopoietic cells lead to expres-
sion of anemia, B6/BMDmtDNA mice would show anemic phe-
notypes. To test this hypothesis, we analyzed peripheral blood
samples from B6/BMDmtDNA (n = 5; donor BM cells carried
82% DmtDNA) and B6/BMWT mice (n = 5) at 6 months after
transplantation by using an automated blood counter. Red
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Fig. 1. Respiratory chain complex activities and ATP contents in BM
cells of mito-mice. (A) Activities of respiratory chain complexes in BM
cells from 5- to 7-month-old WT B6 mice and mito-mice (n = 5 each)
were quantiﬁed. The BM cells from mito-mice carried 78–82%
DmtDNA. (B) ATP contents in 2 · 104 BM cells from 5- to 7-
month-old WT B6 mice and mito-mice (n = 5 each) were measured.
The BM cells from mito-mice carried 77–83% DmtDNA. Values show
mean ± S.D. Asterisks indicate signiﬁcant diﬀerences (P < 0.05).
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were signiﬁcantly decreased in the B6/BMDmtDNA mice. Re-
sults of mean corpuscular volume indicated that RBCs of the
B6/BMDmtDNA mice were larger than those of the B6/BMWT
mice (Table 1). This result suggests that B6/BMDmtDNA mice
suﬀered from macrocytic anemia.Table 1
Complete blood count comparison between B6/BMWT and
B6/BMDmtDNA mice
B6/BMWT B6/BMDmtDNA
Hematocrit (%) 46.6 ± 2.3 34.7 ± 2.1*
Red cell count (·106 cells/mL) 9.7 ± 0.4 6.0 ± 0.4*
HGB (g/dl) 14.8 ± 0.6 11.1 ± 0.7*
MCV (ﬂ) 47.9 ± 2.3 57.6 ± 1.6*
MCHC (g/dl) 31.8 ± 0.5 31.9 ± 0.6
Reticulocyltes (·104 cells/mL) 58.2 ± 9.1 62.7 ± 9.4
Peripheral blood samples from both groups (n = 5 each) were taken a
6 months after transplantation of BM from WT B6 mouse and mito
mouse. Each parameter was measured with an automated blood
counter. Donor BM from mito-mice carried 81% and 82% DmtDNA
HGB, hemoglobin; MCV, mean corpuscular volume; MCHC, mean
corpuscular hemoglobin concentration. Asterisks indicate signiﬁcan
diﬀerences (P < 0.05).
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Fig. 2. Analyses of peripheral blood of B6/BMDmtDNA mice. (A) RBC
lifespans of B6/BMWT and B6/BMDmtDNA mice were estimated by the
biotin-labeled method (n = 5 each). (B) Reticulocyte numbers in
peripheral blood from were estimated after intraperitoneal injection
of PHZ (20 mg per kg of body weight) into B6/BMWT and B6/
BMDmtDNA mice (n = 5 each). Reticulocytes were identiﬁed by ﬂow
cytometry using thiazole orange reagents. Donor BM cells from mito-
mouse carried 81% and 82% DmtDNA. Values show mean ± S.D.
Asterisk indicates signiﬁcant diﬀerence (P < 0.05).t
-
.
tThe anemia in the B6/BMDmtDNA mice could be due to early
disruption of RBCs, deﬁciency in RBC maturation, or both.
To elucidate whether the anemia was caused by enhanced
hemolysis of RBCs, we measured the cell lifespan in B6/
BMDmtDNA (donor BM cells carried 81% DmtDNA; n = 5)
and B6/BMWT mice (n = 5) at 5 months after transplantation
by using the biotin label method [17,18]. There was no signif-
icant diﬀerence between the two groups (Fig. 2A). Further-
more, to evaluate maturation processes of RBCs, we
estimated the absolute number of reticulocytes in peripheral
blood from both groups at 6 months after transplantation, be-
cause reticulocytes are immature RBCs and normally mature
within 2 days [19]. The absolute number of reticulocytes did
not change (Table 1). These results show that the anemia is
not resulted from enhancement of hemolysis and that a similar
number of reticulocytes in the B6/BMDmtDNA mice as that in
the B6/BMWT mice did not lead to recovery from the anemia,
suggesting that reticulocyte maturation is defective in the B6/
BMDmtDNA mice.
To test further the erythropoietic response to a stressful con-
dition, we measured reticulocyte numbers of BM-transplanted
mice after injection of phenylhydrazine (PHZ). B6/BMDmtDNA
(donor BM cells carried 81% DmtDNA; n = 5) and B6/BMWT
mice (n = 5) at 8 months after transplantation were used in this
test. Injection of PHZ could induce acute hemolytic anemia.
Although reticulocyte numbers of both groups were increased
at 3 days after PHZ injection, the increase level was weak in
S.-I. Inoue et al. / FEBS Letters 581 (2007) 1910–1916 1913B6/BMDmtDNA mice. The peak time and value of reticulocytes
delayed and were lower in B6/BMDmtDNA mice, compared with
those in B6/BMWT mice (Fig. 2B). This result suggests that the
erythropoietic response to anemic stimulation is defective in
the B6/BMDmtDNA mice.
3.3. Respiration defects-induced anemia leads to impairment
of erythroblast diﬀerentiation
The spleens of B6/BMDmtDNA mice (donor BM cells carried
82% DmtDNA; n = 5) were enlarged compared with those of0 
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both groups. After immunoﬂuorescent staining with PE-conjugated ant
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indicate signiﬁcant diﬀerences (P < 0.05).B6/BMWT mice (n = 5) at 6 months after transplantation
(Fig. 3A). We estimated proportions of each type of diﬀerenti-
ated cell in spleens from both groups. The proportion of
Ter119-positive erythroblasts in spleens was signiﬁcantly in-
creased in the B6/BMDmtDNA mice (Fig. 3B). The reduced pro-
portion of B220-positive B lymphocytes in spleens of the B6/
BMDmtDNA mice would be inﬂuenced by the large amount of
erythroblasts. However, erythroblasts (Ter119-positive cells)
of BM cells were not signiﬁcantly increased in the B6/
BMDmtDNA mice (data not shown). Mac1&Gr1 Ter119 
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showed markedly enlarged red pulp with a large amount of
erythroblasts (Fig. 3C). We performed ﬂow cytometry assay
with two cell-surface markers to determine the maturation
stage of diﬀerentiating erythroblasts in hematopoietic tissues
[20]. A transferrin receptor (CD71) is expressed on erythro-
blasts during early diﬀerentiation, and its expression is reduced
with cell maturation [21]. A Ter119 antigen is expressed during
terminal diﬀerentiation [22]. We quantiﬁed relative pro-
portions of erythroblasts in the following four popula-
tions: CD71highTer119med (E-I), CD71highTer119high (E-II),
CD71medTer119high (E-III), and CD71lowTer119high (E-IV).
Although proportions of early-stage erythroblasts of E-II
and late-stage erythroblasts of E-IV did not change signiﬁ-
cantly in BM cells of either line, proportions of E-I early-stage
erythroblasts and E-III erythroblasts in B6/BMDmtDNA mice
were increased by 2.0· and 2.6· (Fig. 3D–E). On the other
hand, early-stage erythroblasts (E-I and E-II) of spleens from
the B6/BMDmtDNA mice were markedly increased (7.3· and
4.3·, respectively; Fig. 3F–G). We could not detect any alter-
ation in their maturation between erythroblasts of BM from
both mice groups (data not shown). These results show that
proportions of early-stage erythroblasts are signiﬁcantly in-
creased in spleens from the B6/BMDmtDNA mice, and slightly
increased in BM, suggesting that erythroblast diﬀerentiation
was impaired by respiration defects.
Next, we further examined whether diﬀerentiation of erythro-
blasts are impaired by respiration defects. Cell size can be used
to classify diﬀerentiation stages of erythroblasts, as erythro-
blasts become smaller with their diﬀerentiation [23]. Using for-
ward-scatter of ﬂow cytometry, we estimated the relative size of
erythroblasts in each diﬀerentiation stage of BM at 6 months
after transplantation, resulting in the erythroblast size de-
creased with their diﬀerentiation (E-II to E-IV) in BM of both
groups, however, early-stage erythroblasts (E-II) in BM of the
B6/BMDmtDNA mice were 17% larger than in the B6/BMWT
mice, and late-stage erythroblasts were 29% larger. This result
suggests that respiration defects induce deﬁciency of erythro-
blast diﬀerentiation, resulting in overgrowth of erythroblasts.3.4. Respiration defects slightly enhance apoptosis of
late-stage erythroblasts
Respiration defects in hematopoietic cells induced enlarge-
ment of early-stage erythroblast populations. However, this
enlargement did not lead to enrichment of reticulocytes in
the B6/BMDmtDNA mice (Table 1). Since we previously showed
that high accumulation of DmtDNA induced in vivo apoptosis
of kidney cells in mito-mice [24], we considered that enhanced
apoptosis would occurred in erythroblast stages due to respira-
tion defects. Thus, to investigate whether respiration defects
enhance apoptosis of erythroblasts in B6/BMDmtDNA mice
(donor BM cells carried 80% and 82% DmtDNA; n = 5 each),
we immunostained spleen and BM cells with anti-CD71 and
anti-Ter119 antibodies and incubated them with annexin-V
and proportion of the apoptotic erythroblasts compared with
those in of B6/BMWT mice (n = 10). Unexpectedly, we could
not detect signiﬁcant change in annexin-V-positive rate of
not only E-II erythroblasts in BM and spleen of either group
but also E-IV erythroblasts (Fig. 4). These results suggest that
accumulation of DmtDNA does not signiﬁcantly enhance
apoptosis of erythroblasts.4. Discussion
In this study, we generated a novel in vivo mouse model car-
rying DmtDNA only in hematopoietic cells by transplanting
BM from mito-mice and elucidated that hematopoietic cell-
speciﬁc respiration defects caused by accumulation of
DmtDNA are responsible for the expression of anemia.
There would be some possible mechanisms of this mitochon-
drial anemia. The ﬁrst possible mechanism of the mitochon-
drial anemia could be abnormalities in survival and/or
maturation of peripheral RBCs caused by respiration defects.
If B6/BMDmtDNA mice suﬀer from hemolytic anemia, RBC life-
span of B6/BMDmtDNA mice would shorter than that of B6/
BMWT mice. However, the RBC lifespan were similar in both
groups (Fig. 2A). This data suggests that hemolysis of RBCs is
not increased in this mitochondrial anemia. Reticulocytes
mature within 2 days [19]; therefore reticulocyte levels should
represent the mature RBC supply after 2 days. Thus, if reticu-
locyte maturation rates are similar in both groups, the supply
of mature RBCs in B6/BMDmtDNA mice would be similar to
that in B6/BMWT mice. B6/BMDmtDNA mice show similar
absolute-number of reticulocytes as B6/BMWT mice in periph-
eral blood (Table 1). These issues suggest that respiration de-
fects in reticulocyte production would slow or block their
maturation. Degradation of mitochondria is an important pro-
cess during maturation of RBCs. It has been reported that
ATP-dependent proteolysis would be involved in the process,
because large amounts of ATP are consumed during RBC
maturation [25,26]. Thus, the degradation of mitochondria in
B6/BMDmtDNA mice, which are defective in ATP production,
would take longer than in B6/BMWT mice.
The second possible mechanism of the mitochondrial anemia
could be abnormalities in erythropoietic response to anemic
stress due to respiration defects. In general, anemic condition
induces increasing of reticulocyte counts and lead to recovery
from anemia. Nevertheless, B6/BMDmtDNA mice did not show
increasing of reticulocyte level. Thus, we tested whether ery-
throblasts in B6/BMDmtDNA mice have normal ability to cope
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sult showed that erythropoietic response in B6/BMDmtDNA
mice was relatively insensitive to the anemic stress (Fig. 2B).
The third possible mechanism of the mitochondrial anemia
could be defective diﬀerentiation and/or enhanced apoptosis
of erythroblasts caused by respiration defects. Although many
erythroblasts existed in B6/BMDmtDNA mice (Fig. 3), the abso-
lute number of reticulocytes was not increased in their periph-
eral blood (Table 1). Furthermore, we found that although
erythroblasts from B6/BMDmtDNA mice grew smaller with their
diﬀerentiation (E-II to E-IV) [23] as those from B6/BMWT
mice, they were signiﬁcantly larger than those from B6/BMWT
mice. These results indicate that respiration defects in erythro-
blasts delay or block diﬀerentiation, but do not arrest their
growth. Although we previously showed that high accumula-
tion of DmtDNA induced in vivo apoptosis of kidney cells in
mito-mice, enhancement of erythroblast apoptosis in B6/
BMDmtDNA mice was not observed (Fig. 4). This suggests that
apoptotic response to respiration defects is tissue-speciﬁc.
Severe sideroblastic anemia is one of the major signs of Pear-
son syndrome [4–7]. Thus, there has been possible that respira-
tion defects give rise to sideroblasts [4–7,9,10]. However, we
found no sideroblasts, erythroblasts carrying an excessive
accumulation of iron, in mito-mice or B6/BMDmtDNA mice
(data not shown). Since respiration chain complexes are major
energy production sites and use a large amount of electrons, it
has been supposed that inhibition of mitochondrial respiration
accelerates ROS production [1]. Moreover, it has been re-
ported that the absence of mitochondrial superoxide dismutase
(SOD2) induced a high generation of reactive oxygen species
(ROS) and resultant sideroblastic anemia [18,27]. We found
some increase of superoxide in RBCs in mito-mice or B6/
BMDmtDNA mice (data not shown). If high generation of
ROS leads to iron deposition in erythroblasts, the ROS levels
in erythroblsts of mito-mice and B6/BMDmtDNA mice may be
insuﬃcient to lead to excessive accumulation of iron. However,
in the tissues of SOD2-null mice, high generation of ROS lead
to respiration defects [28]. Therefore, it remains to be deter-
mined whether accumulation of iron is caused by high genera-
tion of ROS or respiration defects themselves in hematipoietic
cells. Since anemic phenotypes without sideroblasts were ob-
served in this study, accumulation of iron itself may not lead
to expression of anemia.
Our results prove a direct link between mitochondrial
respiration defects and expression of anemia. However, the
molecular mechanism of erythroid abnormalities in mitochon-
dria-related anemia is poorly understood. It has been previ-
ously shown that Snf2h, a chromatin-remodeling ATPase
[29], is required for the development of erythroid colonies from
early hematopoietic progenitors [30]. Normal level of ATP
molecules may be important for the function of some chroma-
tin remodeling ATPases in maintaining normal erythropoiesis.
In this report, we showed that respiration defects signiﬁcantly
reduce the content of ATP in BM cells of mito-mice (Fig. 1B).
Thus, the reduction of ATP contents may induce dysfunction
of some chromatin remodeling ATPases and lead to mitochon-
dria-related anemia.
The results of this study show the importance of mitochon-
drial respiration for maintaining normal erythropoiesis. This
ﬁnding could further our understanding not only of mitochon-
drial diseases, but also of anemia. We believe that additional
analyses of hematopoietic cells carrying a high proportion ofDmtDNA would elucidate some molecular mechanisms of ery-
throid abnormalities induced by mitochondrial respiration de-
fects.
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